Hostname: page-component-5c6d5d7d68-vt8vv Total loading time: 0.001 Render date: 2024-08-08T12:16:10.735Z Has data issue: false hasContentIssue false

P0288 - Sudafed for sertindole-induced decreased ejaculatory volume

Published online by Cambridge University Press:  16 April 2020

J. Nielsen*
Affiliation:
Unit for Psychiatric Research, Aalborg Psychiatric Hospital, Aalborg, Denmark

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Sexual dysfunction is very common among patients with schizophrenia. Sertindole is a non-sedating atypical antipsychotic drug with a low incidence of extra pyramidal side-effects. Male patients treated with sertindole often complain of decreased ejaculatory volume. This might be due to the α1 noradrenergic antagonist properties of sertindole. Whether the decreased ejaculatory volume is due to a retrograde ejaculation or due to the fact that the vas deferens is not contracted is unknown. Decreased ejaculatory volume or dry orgasm can be very intimidating for patients with schizophrenia because it might lead to feelings of not being a male or in worst case delusions about disappearing of the semen.

We investigated whether pseudoephedrine (brand name SUDAFED) can reverse the decreased ejaculatory volume induced by sertindole. Pseudoephedrine is an over-the-counter medication used for nasal congestion. Pseudoephedrine is a sympatomimetic amine with α1 agonist properties and is sometimes used for retrograde ejaculation caused by α1 blocking drugs used for benign prostatic hyperplasia. Patients were asked about quality of orgasm, changes in ejaculation volumen and other sexual problems during treatment with sertindole.

Type
Poster Session I: Neuroleptics and Antipsychotics
Copyright
Copyright © European Psychiatric Association 2008
Submit a response

Comments

No Comments have been published for this article.